JCR PHARMACEUTICALS CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 825 JPY | +0.12% |
|
+2.10% | -29.61% |
| Mar. 21 | US Fed Rate Outlook Catapults Japanese Shares to Fresh 52-Week Peak | MT |
| Mar. 21 | JCR Pharmaceuticals Achieves Neurodegenerative Treatment Research Milestone With Alexion | MT |
| Sales 2024 * | 45.37B 293M | Sales 2025 * | 41.75B 270M | Capitalization | 103B 666M |
|---|---|---|---|---|---|
| Net income 2024 * | 7.24B 46.83M | Net income 2025 * | 6.28B 40.61M | EV / Sales 2024 * | 2.55 x |
| Net Debt 2024 * | 12.66B 81.83M | Net Debt 2025 * | 9B 58.15M | EV / Sales 2025 * | 2.68 x |
| P/E ratio 2024 * |
14.2
x | P/E ratio 2025 * |
16.3
x | Employees | 879 |
| Yield 2024 * |
2.38% | Yield 2025 * |
2.43% | Free-Float | 52.97% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | +0.12% | ||
| 1 week | +2.10% | ||
| Current month | -3.96% | ||
| 1 month | -5.50% | ||
| 3 months | -31.59% | ||
| 6 months | -30.32% | ||
| Current year | -29.61% |
1 week
788.00
841.00
1 month
788.00900.00
Current year
788.001 228.00
1 year
788.001 567.00
3 years
788.003 745.00
5 years
788.003 800.00
10 years
440.253 800.00
| Managers | Title | Age | Since |
|---|---|---|---|
Shin Ashida
CEO | Chief Executive Officer | 81 | 75-09-12 |
Hiroyuki Sonoda
CTO | Chief Tech/Sci/R&D Officer | 45 | 03-03-31 |
Yutaka Honda
ADM | Chief Administrative Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shin Ashida
CEO | Chief Executive Officer | 81 | 75-09-12 |
Toshihide Yoda
BRD | Director/Board Member | 61 | 18-06-26 |
Philippe Fauchet
BRD | Director/Board Member | 65 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.67% | 23 M€ | +4.13% | - | |
| 0.30% | 15 M€ | +5.04% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-16 | 825 | +0.12% | 310 100 |
| 24-04-15 | 824 | -1.32% | 504,600 |
| 24-04-12 | 835 | +5.43% | 1,426,100 |
| 24-04-11 | 792 | -1.98% | 667,300 |
| 24-04-10 | 808 | 0.00% | 306,500 |
Delayed Quote Japan Exchange, April 16, 2024 at 02:00 am EDT
More quotes
JCR Pharmaceuticals Co., Ltd. is a Japan-based company primarily engaged in the pharmaceutical business, as well as the medical and research equipment business. The Company operates in two segments. The Pharmaceutical segment engages in the research, production, purchase and sale of medical drugs and pharmaceutical raw materials. The Medical and Research Equipment segment engages in the purchase and sale of the medical and research equipment.
Sector
Pharmaceuticals
Calendar
2024-05-09
- Q4 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
824
JPY
Average target price
1,557
JPY
Spread / Average Target
+88.97%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -29.61% | 667M | |
| +28.40% | 676B | |
| +24.27% | 559B | |
| -7.77% | 356B | |
| +14.96% | 320B | |
| +4.90% | 286B | |
| +2.62% | 213B | |
| +0.15% | 207B | |
| -9.41% | 199B | |
| -7.74% | 142B |
- Stock Market
- Equities
- 4552 Stock
